open access

Vol 2, No 1 (2013)
Review
Published online: 2013-04-10
Get Citation

Individualization of oral antidiabetic therapy in patients with type 2 diabetes

Władysław Grzeszczak
Diabetologia Kliniczna 2013;2(1):14-22.

open access

Vol 2, No 1 (2013)
Review
Published online: 2013-04-10

Abstract

Diabetes causes signifi cant deterioration in the quality
of life and contributes signifi cantly to shorten survival.
Therefore, efforts should be made to in the fi rst place
to prevent or delay the onset of diabetes, and after
diagnosis of the disease as effectively as possible to
treat it. Treatment of diabetic patients must be individualized. The individualized management of patients
with diabetes, including patients with type 2 diabetes
should be considered to prevent or delay the onset
of diabetes including type 2 diabetes, set individual
targets for the treatment of diabetes and very carefully
selected medications for diabetes, blood pressure-
-lowering and lipid-lowering taking into account the
needs of clinical patient.

Abstract

Diabetes causes signifi cant deterioration in the quality
of life and contributes signifi cantly to shorten survival.
Therefore, efforts should be made to in the fi rst place
to prevent or delay the onset of diabetes, and after
diagnosis of the disease as effectively as possible to
treat it. Treatment of diabetic patients must be individualized. The individualized management of patients
with diabetes, including patients with type 2 diabetes
should be considered to prevent or delay the onset
of diabetes including type 2 diabetes, set individual
targets for the treatment of diabetes and very carefully
selected medications for diabetes, blood pressure-
-lowering and lipid-lowering taking into account the
needs of clinical patient.
Get Citation

Keywords

type 2 diabetes, oral antidiabetic agents, individualization procedure

About this article
Title

Individualization of oral antidiabetic therapy in patients with type 2 diabetes

Journal

Clinical Diabetology

Issue

Vol 2, No 1 (2013)

Pages

14-22

Published online

2013-04-10

Bibliographic record

Diabetologia Kliniczna 2013;2(1):14-22.

Keywords

type 2 diabetes
oral antidiabetic agents
individualization procedure

Authors

Władysław Grzeszczak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl